Dana Ullman, one of our greatest voices for homeopathy, takes on the latest absurd FTC ruling with regard to homeopathy. “Extreme Bias in FTC’s Ruling on Homeopathic Medicine.” My life was literally saved by a homeopathic remedy, and I saw enormous benefit to patients in my years of homeopathic practice. Furthermore, there is a plethora of research confirming the effectiveness of this modality. Yet it is attacked again and again and again. I wonder why? Competition to the world of orthodox medicine and pharma drugs? Could that possibly be the case?
An excerpt from Dana Ullman’s article: “Ultimately, homeopathy is the “original nanomedicine,” and the entire field of nanomedicine is so hot that some reports estimate that it will be a $130 billion industry this year. It is hard to avoid the possibility that Big Pharma is pressuring the FTC to rid itself of any competition, even though homeopathy itself is only $1 billion industry in the US.
“The F.T.C. report on homeopathy carefully avoided reference to the largest review of research on homeopathy that has ever taken place. The Swiss government’s “Health Technology Assessment” on homeopathic medicine is much more comprehensive than any previous governmental report written on this subject to date. Not only did this report carefully and comprehensively review the body of evidence from randomized double-blind and placebo controlled clinical trials testing homeopathic medicines, they also evaluated the “real world effectiveness” with observational studies (discussed below) as well as safety and cost-effectiveness. The report also conducted a highly-comprehensive review of the wide body of preclinical research (fundamental physio-chemical research, botanical studies, animal studies, and in vitro studies with human cells) as well as epidemiological studies and cost-effectiveness studies.”